当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析 - 现金流量表

天康生物

(002100)

  

流通市值:107.45亿  总市值:107.45亿
流通股本:13.65亿   总股本:13.65亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金8,142,789,800.334,151,172,156.117,779,967,165.913,298,965,198.77
  收到的税费返还--3,850,713.39831,975.87
  收到其他与经营活动有关的现金92,437,085.2925,731,811.79404,550,640.3374,026,164.78
  经营活动现金流入小计8,235,226,885.624,176,903,967.8918,188,368,519.6213,373,823,339.42
  购买商品、接受劳务支付的现金5,872,126,612.793,188,954,869.3216,422,448,004.429,767,523,724.08
  支付给职工以及为职工支付的现金403,882,949.58163,202,298.77803,145,852.11578,269,789.55
  支付的各项税费89,307,127.341,682,811.42163,319,019.31120,561,124.6
  支付其他与经营活动有关的现金373,956,210.351,692,254.64418,593,903.85556,889,670.68
  经营活动现金流出小计6,739,272,899.973,445,532,234.1517,807,506,779.6911,023,244,308.91
  经营活动产生的现金流量净额1,495,953,985.65731,371,733.74380,861,739.932,350,579,030.51
二、投资活动产生的现金流量:
  收回投资收到的现金255,000,000255,000,000366,399,874-
  取得投资收益收到的现金9,656,811.649,656,811.64901,697.43-
  处置固定资产、无形资产和其他长期资产收回的现金净额272,348.28-4,152,333.55686,699.99
  投资活动现金流入小计264,929,159.92264,656,811.64371,453,904.98686,699.99
  购建固定资产、无形资产和其他长期资产支付的现金152,407,323.535,668,974.73378,950,382.13243,060,965.55
  投资支付的现金-145,000,0001,278,350,687.38-
  取得子公司及其他营业单位支付的现金562,409,619.47---
  支付其他与投资活动有关的现金3,228,771.65-1,600,000-
  投资活动现金流出小计718,045,714.62180,668,974.731,658,901,069.51243,060,965.55
  投资活动产生的现金流量净额-453,116,554.783,987,836.91-1,287,447,164.53-242,374,265.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金--200,870-
  其中:子公司吸收少数股东投资收到的现金--200,870-
  取得借款收到的现金2,698,915,8001,450,000,0005,363,797,240.223,416,687,240.22
  收到其他与筹资活动有关的现金--2,361,300-
  筹资活动现金流入小计2,698,915,8001,450,000,0005,366,359,410.223,416,687,240.22
  偿还债务支付的现金2,840,260,0001,188,664,734.325,408,058,877.064,143,822,504.2
  分配股利、利润或偿付利息支付的现金171,614,883.4135,202,406.67442,613,863.34493,635,228.87
  支付其他与筹资活动有关的现金--151,787,775.63-
  筹资活动现金流出小计3,011,874,883.411,223,867,140.996,002,460,516.034,637,457,733.07
  筹资活动产生的现金流量净额-312,959,083.41226,132,859.01-636,101,105.81-1,220,770,492.85
四、汇率变动对现金及现金等价物的影响---47,027.52-
五、现金及现金等价物净增加额729,878,347.541,041,492,429.66-1,542,733,557.93887,434,272.1
  加:期初现金及现金等价物余额1,410,828,991.971,410,828,991.972,953,562,549.92,672,585,099.42
  期末现金及现金等价物余额2,140,707,339.512,452,321,421.631,410,828,991.973,560,019,371.52
补充资料:
  净利润-494,200,330.27-300,308,190.47-
  资产减值准备44,043,667.65-46,098,106.21-
  固定资产和投资性房地产折旧964,040,805.91-632,842,447.33-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧964,040,805.91-632,842,447.33-
  无形资产摊销16,040,564.41-26,096,302.42-
  长期待摊费用摊销7,533,058.44-15,690,865.66-
  处置固定资产、无形资产和其他长期资产的损失-299,952.37--587,072.68-
  固定资产报废损失14,207,329.49-1,219,644-
  公允价值变动损失-1,712,743.67--807,450.93-
  财务费用64,255,731.16-159,995,645.74-
  投资损失-3,244,415.45--33,827,765.77-
  递延所得税-18,682,177.64--12,654,496.6-
  其中:递延所得税资产减少-14,469,191.12--13,116,112.93-
    递延所得税负债增加-4,212,986.52-461,616.33-
  存货的减少1,242,311,286.64--969,266,841.41-
  经营性应收项目的减少-149,811,612.27-148,490,390.26-
  经营性应付项目的增加-303,038,537.93--236,861,500.52-
  其他--131,543,845.6-
  现金的期末余额2,140,707,339.51-1,410,828,991.97-
  减:现金的期初余额1,410,828,991.97-2,953,562,549.9-
  现金及现金等价物的净增加额729,878,347.54--1,542,733,557.93-
公告日期2026-08-272026-04-302026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑